A strategy putting patients first
Our strategy is focused on pathologies and meeting the needs of clinicians, patients and consumers. We concentrate on infectious diseases - in particular, sepsis, hospital-acquired infections, tuberculosis, AIDS, and hepatitis - as well as on tests delivering high medical value for cancers and cardiovascular diseases.
In applications for the agri-food and biopharmaceutical industries, bioMérieux aspires to be the undisputed leader.
> Read the press realease "bioMérieux 2015" > Open the presentation "2015 strategy"